FUTIBATINIB

Delivery:
oral
Indication:
tumors with specific fibroblast growth factor receptor aberrations: solid tumors, gastric cancer, myelolymphoind neoplasms
Locations:
US EU JP

Fibroblast growth factor receptor (FGFR) 1-4 inhibitor

Link to clinicaltrials.gov